arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Stereotaxis, Inc.

STXS Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus
$1.00
▼ -0.2% Today
as of Oct 22, 16:52 ET
Last 30 days -24.81% Sep 14 → Oct 22
$0.96 $1.08 $1.19 $1.31 $1.43 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$0.98
High
$1.03
Low
$0.98
Volume
$381,256
Avg Vol
$582,426
Mkt Cap
$120M
P/E (TTM)
—
Beta
—
52w High
$3.15
52w Low
$0.95
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 3 items

Oct 22 · 12:04 PR GlobeNewswire
Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia
Oct 20 · 11:40 PR GlobeNewswire
Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026
Sep 16 · 11:59 PR GlobeNewswire
Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026

STXS earnings at a glance

The options market is pricing a move of about ±274.8% after the report, a range of roughly -$1.75 to $3.75 from today's $1.00. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±2.5% on average; after the most recent report on May 12, 2026 it moved +2.1%. That means options currently expect more movement than STXS has typically delivered. STXS beat the consensus EPS estimate in 3 of its last 4 reported quarters. Implied volatility is currently 23%. The share price of $1.00 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.95
$3.15
2% of range
Avg surprise (last 4)
+25.9%
Avg reaction (last 2)
-0.3%
50% positive
Latest IV / EM
2326%
EM ±274.8% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.58$-0.32$-0.06$0.21$0.47 Actual $-0.07Actual $-0.07Actual $-0.07Actual $-0.06Actual $-0.07Actual $-0.08Actual $-0.07Est $-0.07Actual $-0.05Est $-0.07Actual $-0.03Est $-0.06Actual $-0.03Est $-0.04Actual $-0.05 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-6M$-2M$2M$6M$10M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.05 — — — — financials
Tue May 12, 2026Mar/2026 $-0.03 $-0.04 +25.0% +57.1% +2.1% earnings
Tue Nov 11, 2025Sep/2025 $-0.03 $-0.06 +50.0% — — earnings
Thu Aug 7, 2025Jun/2025 $-0.05 $-0.07 +28.6% — — earnings
Mon May 12, 2025Mar/2025 $-0.07 $-0.07 0.0% — -2.8% earnings
Mon Sep 30, 2024Sep 2024 $-0.08 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.07 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.06 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.07 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.07 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.07 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$8M$6M—$7M$9M$7M—$9M
Cost of revenue$3M$2M—$3M$4M$3M—$5M
Gross profit$4M$4M—$4M$5M$4M—$4M
Operating income$-5M$-6M—$-7M$-4M$-6M—$-6M
Net income$-4M$-6M—$-6M$-4M$-6M—$-6M
EPS (diluted)$-0.05$-0.06—$-0.07$-0.05$-0.07—$-0.08

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$10M$15M$13M$11M$7M$11M$12M$11M
Inventory$13M$10M$10M$10M$10M$10M$8M$9M
Total current assets$38M$36M$34M$27M$22M$26M$26M$29M
Total assets$56M$54M$52M$46M$41M$46M$47M$51M
Long-term debt————————
Total liabilities$38M$34M$34M$34M$34M$38M$35M$35M
Total equity$12M$14M$13M$6M$1M$3M$6M$11M

Implied volatility — last 90 days

243%1342%2441%3541%4640% Jun 08 — IV 628% · EM ±82.9%Jun 09 — IV 582% · EM ±73.0%Jun 10 — IV 585% · EM ±69.1%Jun 11 — IV 622% · EM ±68.7%Jun 12 — IV 558% · EM ±57.1%Jun 15 — IV 939% · EM ±67.9%Jun 16 — IV 1256% · EM ±74.2%Jun 17 — IV 1682% · EM ±70.2%Jun 19 — IV 325% · EM ±71.8%Jun 22 — IV 243% · EM ±50.8%Jun 23 — IV 254% · EM ±51.9%Jun 24 — IV 398% · EM ±79.8%Jun 25 — IV 520% · EM ±101.9%Jun 26 — IV 422% · EM ±80.8%Jun 29 — IV 538% · EM ±95.4%Jun 30 — IV 456% · EM ±78.5%Jul 01 — IV 389% · EM ±65.0%Jul 02 — IV 397% · EM ±64.2%Jul 03 — IV 411% · EM ±64.2%Jul 06 — IV 458% · EM ±63.5%Jul 07 — IV 458% · EM ±60.4%Jul 08 — IV 510% · EM ±63.9%Jul 09 — IV 580% · EM ±68.6%Jul 10 — IV 794% · EM ±87.7%Jul 13 — IV 1205% · EM ±100.6%Jul 14 — IV 1469% · EM ±106.2%Jul 15 — IV 1515% · EM ±89.5%Jul 16 — IV 2608% · EM ±108.9%Jul 20 — IV 543% · EM ±128.4%Jul 21 — IV 578% · EM ±134.4%Jul 22 — IV 628% · EM ±143.7%Jul 23 — IV 653% · EM ±146.9%Jul 24 — IV 842% · EM ±186.0%Jul 27 — IV 846% · EM ±176.7%Jul 28 — IV 802% · EM ±164.1%Jul 29 — IV 826% · EM ±165.4%Jul 30 — IV 838% · EM ±164.1%Jul 31 — IV 1016% · EM ±194.4%Aug 03 — IV 1084% · EM ±192.1%Aug 04 — IV 838% · EM ±144.2%Aug 05 — IV 840% · EM ±140.3%Aug 06 — IV 864% · EM ±139.7%Aug 07 — IV 1014% · EM ±158.5%Aug 10 — IV 1078% · EM ±149.3%Aug 11 — IV 1179% · EM ±155.8%Aug 12 — IV 1257% · EM ±157.5%Aug 13 — IV 1359% · EM ±160.6%Aug 14 — IV 1422% · EM ±157.1%Aug 17 — IV 1881% · EM ±157.1%Aug 18 — IV 2287% · EM ±165.4%Aug 19 — IV 2638% · EM ±155.8%Aug 20 — IV 4157% · EM ±173.6%Aug 24 — IV 705% · EM ±147.3%Aug 25 — IV 763% · EM ±156.0%Aug 26 — IV 654% · EM ±131.0%Aug 27 — IV 712% · EM ±139.5%Aug 28 — IV 739% · EM ±141.4%Aug 31 — IV 803% · EM ±142.4%Sep 01 — IV 911% · EM ±156.9%Sep 02 — IV 1000% · EM ±167.1%Sep 03 — IV 867% · EM ±140.3%Sep 04 — IV 898% · EM ±140.3%Sep 07 — IV 1013% · EM ±140.3%Sep 08 — IV 1194% · EM ±157.7%Sep 09 — IV 1270% · EM ±159.1%Sep 10 — IV 1433% · EM ±169.2%Sep 11 — IV 1520% · EM ±167.9%Sep 14 — IV 2070% · EM ±172.9%Sep 15 — IV 2321% · EM ±167.9%Sep 16 — IV 3014% · EM ±178.0%Sep 17 — IV 4640% · EM ±193.8%Sep 21 — IV 750% · EM ±156.7%Sep 22 — IV 820% · EM ±167.9%Sep 23 — IV 794% · EM ±159.1%Sep 24 — IV 851% · EM ±166.7%Sep 25 — IV 945% · EM ±180.8%Sep 28 — IV 1075% · EM ±190.5%Sep 29 — IV 1161% · EM ±200.0%Sep 30 — IV 1197% · EM ±200.0%Oct 01 — IV 1314% · EM ±212.5%Oct 02 — IV 1405% · EM ±219.6%Oct 05 — IV 1570% · EM ±217.5%Oct 06 — IV 1778% · EM ±234.8%Oct 07 — IV 3461% · EM ±433.6%Oct 08 — IV 2326% · EM ±274.8%

Sector peers

HSDT
Solana Company
$112M $2.26-3.0%
VANI
Vivani Medical, Inc.
$110M $1.09-2.7%
HYPR
Hyperfine, Inc.
$92M $0.73-6.2%
NRXS
Neuraxis, Inc.
$90M $7.60-2.8%
ECOR
electroCore, Inc.
$88M $7.41-1.1%
EDAP
EDAP TMS S.A.
$157M $4.320.0%

STXS earnings FAQ

What is STXS's expected move for earnings?

Options currently price a move of about ±274.8%, or $2.75 per share either way from $1.00.

How does STXS stock usually react to earnings?

Across the last 2 reports the average next-day move was ±2.5%, up 1 times and down 1 times.

What is STXS's implied volatility?

STXS's at-the-money implied volatility is about 23% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in